Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

by Global Biodefense Staff January 4, 2021, 1:01 pm
Heading Off The Next Pandemic

by Jim Robbins, KHN January 4, 2021, 10:15 am
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

by JoNel Aleccia, Kaiser Health News December 23, 2020, 12:36 pm
What is the Spike Protein and Why Are Mutations On It Important?

by Connor Bamford December 22, 2020, 12:11 pm
Human Spillover Potential of Reston Ebolavirus Noted by NIAID Study

by Global Biodefense Staff December 22, 2020, 10:23 am
Key Questions on New Variant of SARS-CoV-2 Answered by UK Genomics Researcher

by Lucy van Dorp December 21, 2020, 10:40 am
FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

by Global Biodefense Staff December 19, 2020, 2:02 pm
Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

by JoNel Aleccia, Kaiser Health News December 14, 2020, 5:33 pm
Biodefense Headlines – 13 December 2020

by Global Biodefense Staff December 13, 2020, 6:51 pm
Andes Virus: Outbreak Investigation Reveals Super-Spreader Potential

by Global Biodefense Staff December 7, 2020, 10:57 am
Research Reveals How Airflow Inside a Car May Affect COVID-19 Transmission Risk

by Global Biodefense Staff December 6, 2020, 4:41 pm
How COVID-19 Vaccines Will Get From the Factory to Your Community

by Bahar Aliakbarian December 4, 2020, 9:25 am
Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

by Matthew Woodruff December 3, 2020, 10:52 am
Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights

by Global Biodefense Staff December 3, 2020, 7:19 am

Congratulations. You've reached the end of the internet.

Editor Pick

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

Heading Off The Next Pandemic

At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

What is the Spike Protein and Why Are Mutations On It Important?

Human Spillover Potential of Reston Ebolavirus Noted by NIAID Study

Key Questions on New Variant of SARS-CoV-2 Answered by UK Genomics Researcher

FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

Biodefense Headlines – 13 December 2020

Andes Virus: Outbreak Investigation Reveals Super-Spreader Potential

Research Reveals How Airflow Inside a Car May Affect COVID-19 Transmission Risk

How COVID-19 Vaccines Will Get From the Factory to Your Community

Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

What is the Spike Protein and Why Are Mutations On It Important?

Key Questions on New Variant of SARS-CoV-2 Answered by UK Genomics Researcher

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

Originally Built for Bioterrorism Agents, This Decontamination System Now Clears SARS-CoV-2 from Military Aircraft

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles